Virbac (Virbac) Inventories, Finished Goods

: $220 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

Virbac's quarterly finished goods increased from Jun. 2022 ($198 Mil) to Dec. 2022 ($216 Mil) and increased from Dec. 2022 ($216 Mil) to Jun. 2023 ($220 Mil).

Virbac's annual finished goods increased from Dec. 2020 ($157 Mil) to Dec. 2021 ($195 Mil) and increased from Dec. 2021 ($195 Mil) to Dec. 2022 ($216 Mil).

Virbac Inventories, Finished Goods Historical Data

The historical data trend for Virbac's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 132.70 [6] => 141.00 [7] => 156.97 [8] => 194.71 [9] => 215.53 )

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Inventories, Finished Goods

132.70

141.00

156.97

194.71

215.53

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Inventories, Finished Goods																178.11	194.71	198.49	215.53	219.75

Virbac Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.